Related Experiment Video
Updated: Jun 5, 2026
03:55
A Sensitive Visual Method for the Detection of Hydrogen Sulfide Producing Bacteria
Published on: June 27, 2022
Hydrogen Sulfide-a potent multichannel anti-arrhythmic drug
1Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, P.R. China 100020 zhongguangzhen@hotmail.com.
Journal of Cardiovascular Disease Research
|December 29, 2010
Summary
Hydrogen sulfide shows potential as a novel antiarrhythmic drug by influencing various ion channels. Further research is needed to explore its therapeutic applications for arrhythmias.
Area of Science:
- Cardiovascular Pharmacology
- Electrophysiology
- Gasotransmitter Signaling
Background:
- Arrhythmia poses a significant clinical challenge for cardiologists.
- The development of novel antiarrhythmic drugs with improved efficacy and safety profiles is crucial.
Purpose of the Study:
- To review the multifaceted effects of hydrogen sulfide (H2S) on cardiac ion channels.
- To evaluate the potential of H2S as a therapeutic agent for managing cardiac arrhythmias.
Main Methods:
- Literature review of studies investigating H2S interactions with cardiac ion channels.
- Analysis of experimental data on H2S modulation of ion channel function.
Main Results:
- Hydrogen sulfide exhibits diverse effects on various cardiac ion channels, including potassium, sodium, and calcium channels.
- These modulatory actions suggest a significant role in regulating cardiac electrical activity.
Conclusions:
- Hydrogen sulfide demonstrates promising antiarrhythmic properties due to its complex interactions with cardiac ion channels.
- H2S represents a potential candidate for developing new treatments for cardiac arrhythmias.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...